Lexeo Therapeutics Inc
LXEO4.770USD
+0.160+3.47%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
4.770USD+4.770After-hours (ET)
158.33MMarket Cap
LossP/E TTM
Lexeo Therapeutics Inc
4.770
+0.160+3.47%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Total equity
Cash, cash equivalents and short-term investments
-48.82%99.83M
0.04%121.52M
342.95%157.02M
284.24%174.98M
231.43%195.06M
--121.47M
--35.45M
--45.54M
--58.85M
- Cash and cash equivalents
-85.18%28.91M
-71.17%35.01M
342.95%157.02M
284.24%174.98M
231.43%195.06M
--121.47M
--35.45M
--45.54M
--58.85M
-Short-term investments
--70.92M
--86.50M
----
----
----
----
----
----
----
Prepaid expenses
79.70%5.44M
62.94%4.60M
72.42%2.44M
12.10%2.17M
66.60%3.03M
--2.83M
--1.41M
--1.93M
--1.82M
Other current assets
--0.00
----
----
----
----
--3.00K
--2.01M
--1.24M
--550.22K
Total current assets
-46.86%105.27M
1.47%126.12M
310.19%159.46M
263.67%177.15M
223.56%198.09M
--124.29M
--38.87M
--48.71M
--61.22M
Non-current assets
Net Fixed Assets
-14.59%10.13M
-13.90%10.56M
-11.45%11.15M
-10.55%11.61M
-11.06%11.86M
--12.26M
--12.60M
--12.97M
--13.34M
-Fixed Assets
-10.51%11.47M
-9.98%11.83M
-6.19%12.46M
-3.71%12.73M
-5.29%12.81M
--13.14M
--13.29M
--13.22M
--13.53M
-Accumulated depreciation
40.42%1.33M
44.61%1.27M
89.86%1.31M
352.61%1.13M
399.26%950.00K
--881.00K
--690.00K
--249.00K
--190.28K
Other non-current assets
-0.12%3.25M
0.00%3.25M
0.00%3.25M
0.00%3.25M
-0.29%3.25M
--3.25M
--3.25M
--3.25M
--3.26M
Total non-current assets
35.06%20.42M
34.22%20.82M
-9.10%14.41M
-8.44%14.86M
-8.95%15.12M
--15.51M
--15.85M
--16.23M
--16.60M
Total assets
-41.05%125.69M
5.10%146.94M
217.71%173.87M
195.67%192.01M
173.96%213.21M
--139.81M
--54.72M
--64.94M
--77.82M
Liabilities
Current liabilities
-Other payables
280.11%669.00K
455.62%939.00K
204.40%554.00K
-85.34%184.00K
-28.21%176.00K
--169.00K
--182.00K
--1.25M
--245.17K
Accrued expenses
6.74%15.53M
21.93%12.82M
12.70%15.14M
43.81%10.22M
129.66%14.55M
--10.51M
--13.44M
--7.11M
--6.33M
Short-term debt and lease liabilities
-0.57%521.00K
10.04%570.00K
-87.70%574.00K
8.33%572.00K
0.16%524.00K
--518.00K
--4.67M
--528.00K
--523.16K
-Short-term debt
----
----
----
----
----
----
--4.15M
----
----
-Short-term lease liabilities
-0.57%521.00K
10.04%570.00K
10.60%574.00K
8.33%572.00K
0.16%524.00K
--518.00K
--519.00K
--528.00K
--523.16K
Other current liabilities
280.11%669.00K
455.62%939.00K
204.40%554.00K
-85.34%184.00K
-28.21%176.00K
--169.00K
--182.00K
--1.25M
--245.17K
Total current liabilities
42.50%30.82M
32.53%22.85M
16.42%26.82M
38.19%18.88M
57.95%21.63M
--17.24M
--23.04M
--13.66M
--13.69M
Non-current liabilities
Long-term debt and lease liabilities
-18.97%6.05M
-17.33%6.44M
-16.29%6.79M
-15.12%7.14M
-14.36%7.47M
--7.79M
--8.11M
--8.41M
--8.72M
-Long-term lease liabilities
-18.97%6.05M
-17.33%6.44M
-16.29%6.79M
-15.12%7.14M
-14.36%7.47M
--7.79M
--8.11M
--8.41M
--8.72M
Other non-current liabilities
--0.00
----
----
----
----
----
----
----
----
Total non-current liabilities
-21.72%6.75M
-19.69%7.25M
-18.42%7.72M
-17.06%8.18M
-16.08%8.63M
--9.03M
--9.46M
--9.87M
--10.28M
Total liabilities
24.19%37.58M
14.57%30.10M
6.28%34.54M
15.02%27.06M
26.21%30.25M
--26.27M
--32.50M
--23.52M
--23.97M
Shareholders' equity
Common equity
3.76%401.01M
34.45%397.13M
8023.59%393.59M
9826.67%389.72M
13126.00%386.47M
--295.38M
--4.84M
--3.93M
--2.92M
Preferred equity
----
----
----
----
----
----
--185.03M
----
----
Retained earnings
-53.71%-312.83M
-54.08%-280.17M
-51.65%-254.25M
-52.33%-224.76M
-51.76%-203.52M
---181.84M
---167.65M
---147.54M
---134.10M
Capital reserves
3.76%401.01M
34.45%397.13M
8023.53%393.58M
9826.59%389.72M
13133.64%386.47M
--295.37M
--4.84M
--3.93M
--2.92M
Less: Treasury stock
--17.00K
--17.00K
--13.00K
--13.00K
----
----
----
----
----
Gains losses not affecting retained earnings
---54.00K
---103.00K
----
----
----
----
----
----
----
Total equity
-51.84%88.11M
2.91%116.84M
526.89%139.33M
298.29%164.95M
239.73%182.95M
--113.53M
--22.23M
--41.41M
--53.85M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
